FREQUENCY AND FACTORS LEADING TO SELF-MEDICATION IN PATIENTS WITH ACNE VULGARIS
DOI:
https://doi.org/10.70520/kjms.v18i3.660Keywords:
Self- medication, Prevalence, Acne Vulgaris, Drug ResistanceAbstract
Introduction: Acne vulgaris is a prevalent inflammatory skin disorder. Its prevalence persists into adulthood, even though it is frequently thought of as a self-limiting adolescent illness.
Objective: To determine the prevalence and typical causes of self-medication among acne vulgaris patients.
Methods: This cross-sectional study was conducted from 13/2/2022 to 13/8/2022 at the Department of Dermatology, Hayatabad Medical Complex, Peshawar. Each patient had a comprehensive clinical examination and history. In order determine the prevalence of self-medication and its common factors; drug knowledge, prior prescription, convenience of access, mildness of condition, and lack of time, all patients underwent extensive interviews.
Results: The results of the study demonstrate that out of 145 patients, the average age was 30 years with a standard deviation of ±10.47. Among them, 77 (53%) were female and 68 (47%) were male. Moreover, 88 (61%) patients practiced self-medication. The common contributing factors included drug knowledge (8%), mildness of illness (20%), easy availability (37%), previous prescription (19%), and lack of time (15%).
Conclusion: This study concluded that 61% of individuals with acne vulgaris practiced self-medication. The common contributing factors included drug knowledge (9%), easy availability (37%), previous prescription (19%), mildness of disease (20%), and lack of time (15%).
References
1. Campbell CE, Strassmann BI. The blemishes of modern society? Acne prevalence in the Dogon of Mali. Evolution, medicine, and public health. 2016 Jan 1;2016(1):325-37.
2. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolescent health, medicine and therapeutics. 2016 Jan 19:13-25.
3. Sharma RK, Dogra S, Singh A, Kanwar AJ. Epidemiological patterns of acne vulgaris among adolescents in North India: a cross-sectional study and brief review of literature. Indian journal of paediatric dermatology. 2017 Jul 1;18(3):196-201.
4. Chuah SY, Goh CL. The impact of post-acne scars on the quality of life among young adults in Singapore. Journal of cutaneous and aesthetic surgery. 2015 Jul 1;8(3):153-8.
5. Pandey P, Suresh M, Dubey V, Pandey P. A cross-sectional study on quality of life among acne vulgaris patients. Int J Res Med Sci. 2016 Nov;4(11):4800-5.
6. Nabil Hussien N, A Hassan R, A Nofal A. Prevalence and risk factors of acne vulgaris in adolescents in Belbis City, Sharkia governorate, Egypt: a cross-sectional study. The Egyptian Family Medicine Journal. 2019 Jan 1;3(1):1-4.
7. Sanai M, Shaukat S, Ghias A, Asghar A, Nadeem M, Ahmad TJ. Efficacy and safety of spironolactone in moderate to severe acne in females. Journal of Pakistan Association of Dermatologists. 2019 Sep 1;29(1):101-9.
8. Pena S, Hill D, Feldman SR. Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris. Journal of the American Academy of Dermatology. 2016 Jun 1;74(6):1252-4.
9. Raikar DR, Manthale NS. A cross sectional study of self-medication for acne among undergraduate medical students. Int J Res Dermatol. 2018 Apr 25;25(4):2.
10. Karamata VV, Gandhi AM, Patel PP, Desai MK. Self-medication for acne among undergraduate medical students. Indian journal of dermatology. 2017 Mar 1;62(2):178-83.
11. Faghihi G, Mokhtari F, Fard NM, Motamedi N, Hosseini SM. Comparing the efficacy of low dose and conventional dose of oral isotretinoin in treatment of moderate and severe acne vulgaris. Journal of Research in Pharmacy Practice. 2017 Oct 1;6(4):233-8.
12. Alshehri MD, Almutairi AT, Alomran AM, Alrashed BA, Kaliyadan F. Over-the-counter and prescription medications for acne: A cross-sectional survey in a sample of university students in Saudi Arabia. Indian Dermatology Online Journal. 2017 Mar 1;8(2):120-3.
13. Tan J, Boyal S, Desai K, Knezevic S. Oral isotretinoin: new developments relevant to clinical practice. Dermatologic clinics. 2016 Apr 1;34(2):175-84.
14. Chaudhary A, Patel M, Singh S. Current debates on etiopathogenesis and treatment strategies for Vitiligo. Current Drug Targets. 2022 Oct 1;23(13):1219-38.
15. Chen X, Wang S, Yang M, Li L. Chemical peels for acne vulgaris: a systematic review of randomised controlled trials. BMJ open. 2018 Apr 1;8(4):e019607.
16. Heng AH, Chew FT. Systematic review of the epidemiology of acne vulgaris. Scientific reports. 2020 Apr 1;10(1):5754.
17. Bhat YJ, Latief I, Hassan I. Update on etiopathogenesis and treatment of Acne. Indian journal of dermatology, venereology and leprology. 2017 May 1;83:298.
18. Del Rosso JQ, Tanghetti E. A status report on topical tazarotene in the management of acne vulgaris. Journal of Drugs in Dermatology: JDD. 2013 Mar 1;12(3):s53-8.
19. Thiboutot D, Dréno B, Sanders V, Rueda MJ, Gollnick H. Changes in the management of acne: 2009-2019. Journal of the American Academy of Dermatology. 2020 May 1;82(5):1268-9.
20. Baldwin H, Tan J. Effects of diet on acne and its response to treatment. American journal of clinical dermatology. 2021 Jan;22:55-65.
21. Gamble R, Dunn J, Dawson A, Petersen B, McLaughlin L, Small A, Kindle S, Dellavalle RP. Topical antimicrobial treatment of acne vulgaris: an evidence-based review. American journal of clinical dermatology. 2012 Jun;13:141-52.
